Tirzepatide for hot flashes in post-menopausal women with obesity
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests whether tirzepatide, a weekly injection, can reduce bothersome hot flashes and slow biological aging in post-menopausal women with obesity. It also includes a personalized diet and exercise plan.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 46 and 60 years old.
- You have a body mass index (BMI) of 30 or higher, or 27 or higher with conditions like high blood pressure or sleep apnea.
- You have frequent, bothersome hot flashes (at least 28 over two weeks) that have lasted more than 30 days.
- You are willing to give yourself weekly injections.
- You are willing to follow a reduced-calorie diet and do at least 150 minutes of moderate exercise per week.
- You have not used hormone therapy or other menopause treatments in the past 4 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a GLP-1 agonist medication (like Ozempic) to help postmenopausal women lose weight and improve physical and blood vessel health. It focuses on women aged 46–60 with obesity.
This Phase 2 study tests whether tirzepatide can improve how your body handles fat (especially in people with overweight or obesity) and reduce fat-related “lipotoxicity.” It may help with body fat function and related health markers, but you must meet specific health and medication rules.
This study tests a medicine called tirzepatide to see if it helps people with overweight or obesity lose weight, whether or not they also have type 2 diabetes. Tirzepatide is given as an injection and works on hormones that control appetite.
This trial tests if the weight-loss drug tirzepatide can help people with obesity-related endometrial cancer before their hysterectomy. It may improve surgical outcomes and overall health.
This study tests a medication called tirzepatide (a once-weekly injection) to help teenagers with obesity and related health conditions lose weight. It aims to see if the drug is safe and effective for this age group.
This trial tests if tirzepatide is more effective than standard obesity treatments for adults who have a BMI between 30 and 35 and one weight-related health condition, but do not have diabetes. The goal is to help you lose weight.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.